Jerold Shinbane is a Cardiology physician affiliated with University of Southern California. OpenAlex indexes 113 publications with 4,226 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1520 San Pablo St
Suite 1000
Los Angeles, CA 900335310
Telephone
323-442-5100Provider last certified this registry record 28 Aug 2020.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lantheus Medical Imaging, Inc.Program year20231 payment
- Boston Scientific CorporationProgram year20231 payment
- Bardy Diagnostics, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.3%Beta blocker26.1%Metoprolol Succinate68%Carvedilol15%Metoprolol Tartrate8%Atenolol5%Sotalol3%Part D<11 patientsStatin14.2%Atorvastatin Calcium64%Simvastatin17%Rosuvastatin Calcium10%Pravastatin Sodium9%Part D<11 patients+ 13 more classes in this area
Blood & clotting
19.9%Factor Xa inhibitor15.7%Eliquis88%Xarelto12%Part D<11 patientsVitamin K antagonist2.8%Warfarin Sodium100%Part D≥14 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.8%SGLT2 inhibitor3.4%Jardiance63%Farxiga37%Part D<11 patientsPotassium supplement1.4%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry
European Journal of Clinical Investigation
2024 - Machine Learning-Based Prediction of in-Hospital Death for Patients with Takotsubo Syndrome: The InterTAK-ML Model
European Journal of Heart Failure
2023 - Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry
Journal of the American Heart Association
2021
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”